Nuformix plc (LON:NFX – Get Free Report)’s share price traded down 5.9% during mid-day trading on Wednesday . The company traded as low as GBX 0.24 and last traded at GBX 0.24. 6,983,244 shares were traded during trading, a decline of 87% from the average session volume of 54,786,836 shares. The stock had previously closed at GBX 0.26.
Nuformix Trading Down 5.9%
The stock has a market capitalization of £5.06 million, a price-to-earnings ratio of -0.61 and a beta of 1.22. The firm has a 50-day moving average of GBX 0.30 and a 200-day moving average of GBX 0.17.
About Nuformix
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.
Further Reading
- Five stocks we like better than Nuformix
- What is a Low P/E Ratio and What Does it Tell Investors?
- Market Momentum: 3 Stocks Poised for Major Breakouts
- 5 discounted opportunities for dividend growth investors
- 3 Reasons Casey’s General Stores Will Continue Trending Higher
- 3 Dividend Kings To Consider
- Golden Cross Alert: 3 Stocks With Major Upside Potential
Receive News & Ratings for Nuformix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuformix and related companies with MarketBeat.com's FREE daily email newsletter.
